...
首页> 外文期刊>The Journal of Experomental Medicine >Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
【24h】

Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.

机译:跨异种屏障的特异性耐受诱导:使用非致死性制备方案产生混合的大鼠/小鼠淋巴造血嵌合体。

获取原文
           

摘要

The development of safe methods for inducing donor-specific tolerance across xenogeneic barriers could potentially relieve the critical shortage of allograft donors that currently limits the applicability of organ transplantation. We report here that such tolerance can be induced in a xenogeneic combination (rat---|-mouse) using a nonmyeloablative and nonlethal preparative regimen. Successful induction of chimerism and donor-specific transplantation tolerance required pretreatment of recipients with monoclonal antibodies (mAbs) against NK1.1, Thy-1.2, CD4 and CD8, followed by administration of 3 Gy whole body radiation (WBI), 7 Gy thymic irradiation, and infusion of T cell-depleted rat bone marrow cells (BMC). Rat cells appeared among peripheral blood lymphocytes (PBL) of such recipients by 2-3 wk, and rat T cells by 2-5 wk following bone marrow transplantation (BMT). Donor-type rat skin grafts placed 4 mo after BMT were accepted, while simultaneously placed non-donor-type rat skin grafts were promptly rejected. In addition to its clinical potential, the ability to induce donor-specific tolerance across xenogeneic barriers using such a nonlethal preparative regimen provides a valuable model for the study of mechanisms of xenogeneic transplantation tolerance.
机译:诱导跨异种障碍诱导供体特异性耐受的安全方法的开发可能会缓解同种异体移植供体的严重短缺,这目前限制了器官移植的适用性。我们在这里报告说,这种耐受性可以使用非清髓性和非致死性的制备方案在异种组合(鼠 --- |小鼠)中诱导。成功诱导嵌合体和供体特异性移植耐受性要求接受者针对NK1.1,Thy-1.2,CD4和CD8的单克隆抗体(mAb)进行预处理,然后进行3 Gy全身辐射(WBI),7 Gy胸腺辐射,以及输注贫T细胞的大鼠骨髓细胞(BMC)。骨髓移植(BMT)后,大鼠细胞在2-3周出现在这些受体的外周血淋巴细胞(PBL)中,大鼠T细胞在2-5周出现在大鼠T细胞中。接受BMT后4个月放置的供体型大鼠皮肤移植物,而同时放置的非供体型大鼠皮肤移植物则被迅速拒绝。除了其临床潜力外,使用这种非致死性制备方案诱导跨异种屏障的供体特异性耐受的能力为研究异种移植耐受机制提供了有价值的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号